Targeting Conformational Plasticity of Protein Kinases
- 19 December 2014
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 10 (1) , 190-200
Abstract
The quest for ever more selective kinase inhibitors as potential future drugs has yielded a large repertoire of chemical probes that are selective for specific kinase conformations. These probes have been useful tools to obtain structural snapshots of kinase conformational plasticity. Similarly, kinetic and thermodynamic inhibitor binding experiments provide glimpses at the time scales and energetics of conformational interconversions. These experimental insights are complemented by computational predictions of conformational energy landscapes and simulations of conformational transitions and of the process of inhibitors binding to the protein kinase domain. A picture emerges in which highly selective inhibitors capitalize on the dynamic nature of kinases.Keywords
Funding Information
- Feldstein Medical Foundation
This publication has 99 references indexed in Scilit:
- Recently targeted kinases and their inhibitors—the path to clinical trialsCurrent Opinion in Pharmacology, 2014
- Novel Approaches for Targeting Kinases: Allosteric Inhibition, Allosteric Activation and PseudokinasesFuture Medicinal Chemistry, 2014
- The Structural Basis for Control of Eukaryotic Protein KinasesAnnual Review of Biochemistry, 2012
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Targeting protein kinasesNature Reviews Drug Discovery, 2004
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Kinetic and Catalytic Mechanisms of Protein KinasesChemical Reviews, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000